Metformin and Infections: What Is the Next Step in This Decades-Long Story?-Reference-Cited by-同舟云学术

Metformin and Infections: What Is the Next Step in This Decades-Long Story?

Published:2022-12-23 Issue:7 Volume:76 Page:1245-1246
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Goto Michihiko¹²^ORCID,Perencevich Eli N²³

Affiliation:

1. Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Carver College of Medicine , Iowa City, Iowa , USA

2. Center for Access & Delivery Research and Evaluation, Iowa City Veterans Affairs Health Care System , Iowa City, Iowa , USA

3. Division of General Internal Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine , Iowa City, Iowa , USA

Funder

Centers for Disease Control and Prevention

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciac903/48356422/ciac903.pdf

Reference15 articles.

1. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Davies;Diabetes Care,2022

2. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes—2022;American Diabetes Association Professional Practice Committee;Diabetes Care,2022

3. Metformin: its botanical background;Bailey;Pract Diabetes Int,2004

4. Metformin: historical overview;Bailey;Diabetologia,2017

5. Flumamine, a new synthetic analgesic and anti-flu drug;Garcia;J Philipp Med Assoc,1950

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial;2023-06-07